Assignee
CAMP4 THERAPEUTICS CORP
US·4 granted patents·14 pending applications·3 citations·filing 2018–2025
Top patents by PatentIndex Score
18 records- 0184US11542290B2Phenothiazine derivatives and uses thereofCAMP4 THERAPEUTICS CORP·Filed 2019·Granted Jan 3, 2023·2 cites·6 claims
- 0279US2025034193A1Phenothiazine derivatives and uses thereofCAMP4 THERAPEUTICS CORP·Filed 2024·Application pending·0 cites
- 0376US12145963B2Phenothiazine derivatives and uses thereofCAMP4 THERAPEUTICS CORP·Filed 2022·Granted Nov 19, 2024·0 cites·1 claims
- 0475US12319916B2Modulation of gene transcription using antisense oligonucleotides targeting regulatory RNAsCAMP4 THERAPEUTICS CORP·Filed 2024·Granted Jun 3, 2025·0 cites·15 claims
- 0575US11266655B2Methods and compositions for treating urea cycle disordersCAMP4 THERAPEUTICS CORP·Filed 2020·Granted Mar 8, 2022·1 cites·10 claims
- 0663US2025243488A1Methods of modulating progranulin expression using antisense oligonucleotides targeting regulatory rnasCAMP4 THERAPEUTICS CORP·Filed 2024·Application pending·0 cites
- 0757US2025290072A1Modulation of syngap1 gene transcription using antisense oligonucleotides targeting regulatory rnasCAMP4 THERAPEUTICS CORP·Filed 2025·Application pending·0 cites
- 0855US2022168316A1Methods and compositions for treating urea cycle disordersCAMP4 THERAPEUTICS CORP·Filed 2022·Application pending·0 cites
- 0955US2025250575A1Modulation of gene transcription using antisense oligonucleotides targeting regulatory rnasCAMP4 THERAPEUTICS CORP·Filed 2025·Application pending·0 cites
- 1054US2024360451A1Modulation of gene transcription using antisense oligonucleotides targeting regulatory rnasCAMP4 THERAPEUTICS CORP·Filed 2022·Application pending·0 cites
- 1152US2021118524A1Identifying Therapeutic Targets by Discovering Interactions between Non-Coding Variants and Candidate GenesCAMP4 THERAPEUTICS CORP·Filed 2020·Application pending·0 cites
- 1250US2023282314A1Characterizing functional regulatory elements using machine learningCAMP4 THERAPEUTICS CORP·Filed 2023·Application pending·0 cites
- 1346US2021161997A1Treating diseases via targeted modulation of gene signaling networksCAMP4 THERAPEUTICS CORP·Filed 2019·Application pending·0 cites
- 1445US2025320496A1Modulation of abcb11 gene transcription using antisense oligonucleotides targeting regulatory rnasCAMP4 THERAPEUTICS CORP·Filed 2025·Application pending·0 cites
- 1541US2021254056A1Identification and targeted modulation of gene signaling networksCAMP4 THERAPEUTICS CORP·Filed 2018·Application pending·0 cites
- 1638US2020316038A1Methods and compositions for treating urea cycle disorders, in particular otc deficiencyCAMP4 THERAPEUTICS CORP·Filed 2018·Application pending·0 cites
- 1738US2020208128A1Methods of treating liver diseasesCAMP4 THERAPEUTICS CORP·Filed 2018·Application pending·0 cites
- 1837US2022107328A1Methods of treating liver diseasesCAMP4 THERAPEUTICS CORP·Filed 2019·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →